Table 1.
Completeness of Documentation
| Group and Item | EHR/CPOE (%; n = 45) | Paper (%; n = 45) | P |
|---|---|---|---|
| All patients (n = 90) | |||
| Date of birth | 100 | 100 | — |
| MRN on order | 100 | 13 | < .001 |
| Allergies | 100 | 96 | .494 |
| Plan for treatment | 96 | 84 | .157 |
| No. of cycles planned | 47 | 60 | .205 |
| Cycle length | 100 | 69 | < .001 |
| Height | 96 | 9 | < .001 |
| Weight | 87 | 18 | < .001 |
| BSA | 96 | 20 | < .001 |
| Dose | 100 | 100 | — |
| Dose per unit | 96 | 49 | < .001 |
| Diluent | 100 | 47 | < .001 |
| Route | 100 | 89 | .056 |
| Infusion length | 100 | 56 | < .001 |
| Infusion rate | 11 | 0 | .056 |
| Pre meds (dose, route, frequency) | 100 | 84 | .012 |
| Post meds (dose, route, frequency) | 98 | 80 | .007 |
| Laboratory results | 100 | 84 | .012 |
| Treatment parameters | 87 | 13 | < .001 |
| Physician signature | 100 | 96 | .494 |
| Administration | 100 | 100 | — |
| Pharmacy interventions | 51 | 4 | < .001 |
| Follow-up plan | 100 | 71 | < .001 |
| Clinical trial patients only (n = 8) | |||
| Identified on study | 100 | 75 | 1 |
| Clinical trial note | 100 | 0 | .029 |
| Treatment calendar | 100 | 75 | 1 |
| Study/protocol No. | 100 | 75 | 1 |
Abbreviations: BSA, body surface area; CPOE, computerized physician order entry; EHR, electronic health record; MRN, medical record number.